The WORLDSymposium New Treatment Award for 2024 was presented to Amicus Therapeutics for ipaglucosidase alfa (Pombiliti®) and Chiesi Global Rare Diseases for pegunigalsidase alfa-iwxj (Elfabrio®) and for velmanase alfa-tycv (Lamzede®) More details.
The WORLDSymposium New Treatment Award for 2023 was presented to Sanofi for olipudase alfa-rpcp (Xenpozyme™) More details.
The WORLDSymposium 2022 New Treatment Awards were presented to Sanofi Genzyme and to JCR Pharmaceuticals on Thursday, February 10, 2022. More details.
The WORLDSymposium 2018 New Treatment Awards were presented to Biomarin and to Ultragenyx on Thursday, February 5, 2018. More details.
The WORLDSymposium 2017 New Treatment Award was presented to migalastat (Galafold™). More details.
The WORLDSymposium 2016 New Treatment Award was presented to sebelipase alfa (Kanum™). More details.
The WORLDSymposium 2015 New Treatment Awards were presented to Genzyme, Green Cross Corp, Raptor Pharmaceutical Corp and Biomarin Pharmaceutical at the WORLDSymposium banquet on Thursday, February 12. More details.